Aurora Cannabis posts record full-year results on International Medical growth
Aurora Cannabis (NASDAQ:ACB) reported record global medical cannabis net revenue and adjusted EBITDA for fiscal year 2026, capitalizing on its structural pivot toward high-margin prescription markets in Europe and Australia.

_1419204_640x360_2503275075635-640x360.webp&w=3840&q=75)
_1419189_640x360_2503266883695-640x360.webp&w=3840&q=75)
_1419163_640x360_2503255619754-640x360.webp&w=3840&q=75)



_1419078_640x360_2503234115789-640x360.webp&w=3840&q=75)
_1419070_640x360_2503230531681-640x360.webp&w=3840&q=75)


_1419040_640x360_2503226435565-640x360.webp&w=3840&q=75)